UMMC Navigation

Cardiovascular

Main Content

Cardiovascular Studies

Do you have cardiovascular issues? Do you know someone who has similar health interests or issues? UMMC is conducting clinical research studies to look at potential treatments, medications and other heart-related protocols. If you would like to know more about our efforts, you can visit the links below.

  • A study, referred to as BEAT-HF, is being conducted to see if an experimental device is safe and effective in people with heart failure. Click here for details.
  • A study, referred to as CIRT, is looking at whether taking an approved medication reduces heart attacks, strokes, or death in people with type 2 diabetes or metabolic syndrome who have had a heart attack or multi-vessel coronary artery disease. Click here for details.
  • A study, referred to as DCM Precision Medicine Study, is being conducted to see if Dilated Cardiomyopathy (DCM) may be related to a specific genetic trait and to evaluate the effectiveness of a family communication intervention in improving the instance of clinical screening of family members. Click here for details.
  • A study, referred to as Guided HF, is looking at whether implementation of American Heart Association heart failure treatment guidelines reduces subsequent hospital visits and increases patient satisfaction, knowledge about heart failure, and quality of life in patients who are discharged from the Emergency Department for acute heart failure exacerbations. Click here for details.
  • A study, referred to as INVESTED, is looking at whether one type of approved influenza vaccine will reduce cardiovascular and pulmonary problems more than another type of approved influenza vaccine in patients who have had a heart attack or heart failure. Click here for details.
  • A study, referred to as Nocturnal Hypertension, is looking at whether blood pressure readings collected in a home setting can help assess risk for heart failure. Click here for details.
  • A study, referred to as PARADISE-MI, is looking at using an approved medication in an experimental way to help reduce cardiovascular death, heart failure hospitalization, and outpatient heart failure in people who have recently had a heart attack. Click here for details.
  • A study, referred to as PIONEER-HF, is looking at starting an approved heart failure medication while in the hospital rather than waiting until after being discharged. Click here for details.
  • This study, referred to as REALITY, is being conducted to help doctors gain a better understanding of the treatment of blood vessels in the legs during a routine procedure for treating a blockage in a blood vessel in the upper part of the leg. Click here for details.
  • A study, referred to as RSF and Hypertension, is being conducted to help doctors gain a better understanding of how internal fat leads to kidney damage and high blood pressure. Click here for details.
  • A study, referred to as TAILOR-PCI, is being conducted to help doctors gain a better understanding of the effectiveness of two approved medications in people with acute coronary syndrome or coronary artery disease. Click here for details.
  • A study, referred to as VICTORIA, is looking at a new investigational heart failure medication to see if it is safe and effective in participants with heart failure. Click here for details.
  • A study is looking at the effect of genetics on Long QT syndrome as a risk factor for sudden cardiac death in those with sickle cell disease. Click here for details.
  • A study is looking at the association between vitamin D deficiency and preeclampsia or preterm labor. Click here for details.